-The Hindu Business Line Agreement between Viatris, MedAccess and TBA to slash cost by 34 per cent on pretomanid A new agreement among drugmaker Viatris, MedAccess, and TB Alliance looks to reduce the price of pretomanid, a drug used to treat multidrug-resistant tuberculosis, by 34 per cent. The agreement will help expand access to this critical new treatment in more than 140 countries, including those with the highest TB burden, said a joint...
More »SEARCH RESULT
Total Matching Records found : 4
Centre to launch new anti-TB programme focused on nutrition
-The New Indian Express One of the main thrust areas of the programme will involve encouraging adopting TB patients so that their nutritional needs are met. NEW DELHI: Even as tuberculosis, one of the biggest killers, saw a 19 percent increase in 2021, the Centre has now planned to launch a new programme -- Pradhan Mantri TB Mukt Bharat Abhiyan (PMTBMBA) -- that will encourage financial contributions from not only non-governmental organisations...
More »India reports sharp rise in tuberculosis last year as cases up 19% -Sumi Sukanya Dutta
-Moneycontrol.com During the COVID-19 pandemic, a significant reduction was observed in the total number of drug resistant TB patients started on treatment as compared to 2019. In 2020 and 2021, there was also a reduction of 14 and 9 percent respectively in the number multiple drug resistant TB patients put on treatment India recorded a total of 19,33,381 new and relapsed tuberculosis patients in 2021 marking a rise of 19 percent over...
More »Public Health
KEY TRENDS • The 2019 India TB report says that the country accounted for a quarter of the global tuberculosis (TB) burden with an estimated 27 lakh cases in 2018. In 2018, the country was able to achieve a total notification of 21.5 lakh TB cases, of which 25 percent was from private sector. Majority of the TB burden is among the working age group. Nearly 89 percent of TB cases came from the age group 15-69 years....
More »
